Suchergebnisse - "Aubrey, Brandon J"

PubPharm (22)

1

Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML

enthalten in: Blood | 2024

von Bourgeois, W. | Cutler, J. | Aubrey, B. | +22

CommentIn: Blood. 2024 Apr 11;143(15):1438-1439. - PMID 38602697

2

Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses

enthalten in: Cell death and differentiation | 2024

von La Marca, J. | Aubrey, B. | Yang, B. | +16

3

SOHO State of the Art and Next Questions : Treatment of Higher-Risk Myelodysplastic Syndromes

enthalten in: Clinical lymphoma, myeloma & leukemia | 2022

von Aubrey, B. | Brunner, A.

4

Evidence-Based Minireview : Clinical utilization of panel-based molecular testing for patients with AML

enthalten in: Hematology. American Society of Hematology. Education Program | 2022

von Aubrey, B. | Brunner, A.

5

MOZ and Menin-MLL Complexes Are Complementary Regulators of Chromatin Association and Transcriptional Output in Gastrointestinal Stromal Tumor

enthalten in: Cancer discovery | 2022

von Hemming, M. | Benson, M. | Loycano, M. | +9

6

Loss of TRP53 reduces but does not overcome dependency of lymphoma cells on MCL-1

enthalten in: Cell death and differentiation | 2022

von Aubrey, B. | Brennan, M. | Diepstraten, S. | +5

7

IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia

enthalten in: Nature cancer | 2022

von Aubrey, B. | Cutler, J. | Bourgeois, W. | +22

CommentIn: Nat Cancer. 2022 May;3(5):528-529. - PMID 35624338

8

Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias

enthalten in: Blood | 2021

von Thijssen, R. | Diepstraten, S. | Moujalled, D. | +33

CommentIn: Blood. 2021 May 20;137(20):2711-2712. - PMID 34014291

9

PHF6 regulates hematopoietic stem and progenitor cells and its loss synergizes with expression of TLX3 to cause leukemia

enthalten in: Blood | 2019

von McRae, H. | Garnham, A. | Hu, Y. | +24

CommentIn: Blood. 2019 Apr 18;133(16):1698-1700. - PMID 31000514

10

Mutant TRP53 exerts a target gene-selective dominant-negative effect to drive tumor development

enthalten in: Genes & development | 2018

von Aubrey, B. | Janic, A. | Chen, Y. | +12